Jiangcaoxiang alleviates hepatic fibrosis through the Nrf2/GPX4 signaling pathway: Elucidated via integrated network pharmacology, multi-omics profiling, and experimental validation

This study demonstrates the therapeutic potential of JCX for HF and elucidates its multi-target pharmacological mechanism, thereby providing a foundation for further investigation and clinical application.